HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid → HCID 117727855, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid | HCID 53260165 | — |
| Reactant | 2-((4,4-Difluoropiperidin-2-yl)methyl)isoindoline-1,3-dione | HCID 117728017 | — |
| Reactant | ((2S,3R)-2-(Aminomethyl)-3-methylpiperidin-1-yl)(5-methyl-2-(1-methyl-1H-pyrazol-4-yl)phenyl)methanone | HCID 117728145 | — |
| Product | HCID 117727855 | HCID 117727855 | — |
Reaction Steps
The title compound was prepared following the same general protocol as described for ((2S,3R)-2-(aminomethyl)-3-methylpiperidin-1-yl)(5-methyl-2-(1-methyl-1H-pyrazol-4-yl)phenyl)methanone in Example A1 using 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid and 2-((4,4-difluoropiperidin-2-yl)methyl)isoindoline-1,3-dione. MS (ESI) 336 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09440982B2 |
| Source dataset | uspto-grants-2016_09 |
| ORD ID | ord-50ccac2f3e294a3e9fbf061a167c3080 |
| Source note | uspto-grants-2016_09 |